Pixantrone (BBR 2778) in Patients With Refractory Acute Myelogenous Leukemia (AML)
This study has been completed.
Sponsor:
Cell Therapeutics
Information provided by:
Cell Therapeutics
ClinicalTrials.gov Identifier:
NCT00106600
First received: March 28, 2005
Last updated: August 21, 2007
Last verified: August 2007
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | March 2007 |
| Estimated Primary Completion Date: | No date given |